Value proposition
Our Vision : We have High Standards - We Build Companies - We have Impact
Kurma Partners is a key European venture capital group specialized in healthcare, with €470 million under management, with two dedicated franchises : Kurma Biofund focused on therapeutic (current active fund KBIII) and Kurma Diagnostics focused on diagnostic and digital health (current active fund Kurma Dx2).
Biotechnology, Lifesciences, Drug Development, Technology transfer, Rare diseases, Digital Healh, Diagnostics, and MedtechOriginal language
Our Vision : We have High Standards - We Build Companies - We have Impact
Kurma Partners is a key European venture capital group specialized in healthcare, with €470 million under management, with two dedicated franchises : Kurma Biofund focused on therapeutic (current active fund KBIII) and Kurma Diagnostics focused on diagnostic and digital health (current active fund Kurma Dx2).
Kurma Partners - Major player in the funding of healthcare and biotechnology in Europe
Kurma Partners - Major player in the funding of healthcare and biotechnology in Europe
https://www.kurmapartners.com/en
| Entity | Type | Tweets | Articles | |
|---|---|---|---|---|
 | ARMEN Financial Services | Other | ||
 | BGV (BioGeneration Ventures) | Other 24 Apr 2025 | | |
 | LJA - LA LETTRE DES JURISTES D'AFFAIRES Online Audio and Video Media | Other 18 May 2025 | | |
 | Moonfare Financial Services | Other 13 May 2025 | | |
 | Angelini Ventures | Other 10 May 2025 | | |
 | EDBI Pte Ltd | Other 10 May 2025 | | |
 | CertiPair healthtech | Other 24 Apr 2025 | | |
 | Kima Ventures Venture Capital and Private Equity Principals | Other 2 May 2025 | | |
 | Panakes Partners Venture Capital and Private Equity Principals | Other 1 May 2025 | | |
 | Senti Biosciences Biotechnology Research, biotech, deeptech | Other 31 Jan 2025 | | |